UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
KNSA holding history
Kiniksa Pharmaceuticals International, plc in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KNSA overviewAll 13F holders of KNSAFull Q4 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −37,602−100.0% | Sold out | Holders |
| Q2 2025 | 37,602 | $1.04M | <0.1% | −101,673−73.0% | Reduced | Holders |
| Q1 2025 | 139,275 | $3.09M | 0.1% | +39,643+39.8% | Added | Holders |
| Q4 2024 | 99,632 | $1.97M | <0.1% | +24,463+32.5% | Added | Holders |
| Q3 2024 | 75,169 | $1.88M | <0.1% | −38,826−34.1% | Reduced | Holders |
| Q2 2024 | 113,995 | $2.13M | 0.1% | +19,500+20.6% | Added | Holders |
| Q1 2024 | 94,495 | $1.86M | 0.1% | −6,227−6.2% | Reduced | Holders |
| Q4 2023 | 100,722 | $1.77M | 0.1% | −5,701−5.4% | Reduced | Holders |
| Q3 2023 | 106,423 | $1.85M | <0.1% | −115,000−51.9% | Reduced | Holders |
| Q2 2023 | 221,423 | $3.12M | 0.1% | +5,213+2.4% | Added | Holders |
| Q1 2023 | 216,210 | $2.33M | 0.1% | +216,210 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −140,962−100.0% | Sold out | Holders |
| Q3 2022 | 140,962 | $1.81M | <0.1% | +140,962 | New | Holders |